Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
Expedition Money Launches “Woodland Cents,” a 53-Book Children’s Series That Teaches Kids the Money Habits, Mindset, and Values Behind a Prosperous Life — Not Just the Rules
Relemio Expands Its Ecosystem With Self-Custody, Multi-Chain Support, Staking and Governance
Which Custom Clothing Suppliers Are Best for Premium Clothing Brands? Comparing Fabric, Fit, Wash and Branding
Robert Theodore Shares a Powerful True Story of Survival, Healing, and Hope in A Dime A Dozen
What Were the Untold Years of Jesus Like? Craig Hunt Explores the Question in The Years Between
‘The run ends in the centre of this beautiful village’: readers’ favourite small ski resorts in Europe
‘A form of anti-status status’ – how much would you pay for a plain tote bag?
Winter arrives in markets
Matilda celebrates 15 years as West End success story
Here’s what happened in crypto today
What books had people turning pages and turning up the volume this year?
Ethereum delays Glamsterdam Hoodi testnet launch over security risks
Global tech sell-off sparks flight to safety
Palmer Luckey Made a Genetically Modified Military Dog Startup
What to Know About Shamonda Virus Following the First Reported Human Infection
Tsinghua University and ANTA Group Launch Joint Research Institute for Sports Fashion
PERPETUAL SALES INC. (PSVQ) Makes Digital Content Work at the Point of Purchase
PERPETUAL SALES INC. (PSVQ) Explores Smart Retail for Everyday Life
PERPETUAL SALES INC. (PSVQ) Explores Connecting Inventory, Equipment and Daily Tasks
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute